Organigram Global Inc. cash flow statement

In fiscal 2025, Organigram Global Inc.'s operations generated −$5.4m of cash; it spent $12.2m on capital projects, leaving free cash flow of −$17.6m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Organigram Global Inc.: cash flow statement, annual
Fiscal year	2018Aug 2018	2019Aug 2019	2020Aug 2020	2021Aug 2021	2022Aug 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Cash from operations	−10	−26	−34	−23	−28	−29	3	−5
Depreciation and amortisation	0	1	1	2	4	4	3	6
Stock-based pay	4	11	6	3	4	4	5	3
Capital spending	44	82	57	9	38	22	3	12
Free cash flow	−54	−109	−91	−32	−67	−50	−1	−18
Free cash flow after stock pay	−58	−120	−97	−35	−71	−55	−6	−21

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BTMD vs OGI KMDA vs OGI CRON vs OGI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Organigram Global Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Organigram Global Inc.